EdgeNewswire

SS Innovations International (NASDAQ: SSII) Appoints Sarah Romano as Chief Financial Officer

  • 1 min read
  • SS Innovations NASDAQ: SSII

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Based in the United States, Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors and will help lead the company’s financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.

Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations.

Questions around this news

  1. When will Sarah Romano become chief financial officer?

    Romano’s appointment is effective Aug. 3, 2026. The release says she will help lead the company’s financial operations as it works on its global expansion strategy, which includes seeking U.S. FDA approval for its surgical robotic system.

  2. What experience is Sarah Romano bringing to the role?

    The release says Romano has more than two decades of finance leadership experience in medical technology and life sciences. In prior CFO roles, she raised more than $100 million through public and private financings and oversaw strategic transactions, SEC reporting and investor relations. Most recently, she was CFO of Vicarious Surgical.

  3. What does FDA approval for a surgical robotic system generally involve?

    In general, FDA review assesses whether a medical device meets applicable standards for safety and effectiveness for its intended use. The evidence and review process depend on the device and the regulatory pathway. A company seeking approval typically submits information about the device, its performance and supporting testing for the agency to evaluate.

  4. What does it mean to reduce cash burn?

    Cash burn refers to the pace at which a business uses cash to fund its operations and other activities. Reducing cash burn means lowering that outflow, for example by cutting costs, improving operating efficiency or changing spending plans. The phrase does not, by itself, indicate whether a company is profitable.

To view the full press release, visit https://ibn.fm/pAqlP

About SS Innovations

SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery.  An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.

NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

Corporate Communications

IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
[email protected]

At a glance

Company
SS Innovations International, Inc.
Ticker
NASDAQ: SSII
Announcement
Executive

Key figures

Finance leadership experience
more than two decades
Financings raised in earlier CFO roles
more than $100 million

People

  • Sarah M. RomanoChief financial officer

Products and programs

  • SSi Mantra surgical robotic system
  • SSi Mudra surgical instruments

SEC filings

Earlier from SS Innovations

  1. SS Innovations International (NASDAQ: SSII) Is ‘One to Watch’
  2. SS Innovations International (NASDAQ: SSII) Wins 2026 Surgical Robotics Industry Outstanding Company Award 
Back to News Center
EdgeNewswire

EdgeNewswire distributes your news to a targeted and established network of journalists and media outlets. We help build visibility and credibility for your organization and brand through trusted media coverage.

Copyright © 2024 - 2026   EdgeNewswire – Cutting Edge Press Release Distribution Services. All Rights Reserved.